The evolving role of extended-release buprenorphine (Sublocade®) as a treatment option for opioid use disorder.

Authors: Unknown
Publication:
Published: May 22, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Monetary tightening, financial stability and the role of macroprudential policy

Luis Herrera, Caterina Mendicino et al. - Jul 2026

Read More
L-Theanine for Anxiety: Mechanisms and Adjunctive Role

Noshene E. Ranjbar Noshene E Ranjbar - Jul 2026

Read More
Ports, Technology and Inter-City Trade: The Economics and Geopolitics of Evolving Maritime Transport Networks

Reka Juhasz, Dávid Krisztián Nagy et al. - Jul 2026

Read More
The Rise of Female Autonomy and the Decline of Fertility: The Role of Mismatch

Claudia Goldin - Jul 2026

Read More
Financial Exposure After a Sealed-Source Release: Insurance Limits, Federal Cost Pathways, and Implications for Gamma Irradiator Substitution

Desmond Harmon, Hannah Gagarin - Jul 2026

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Centre Research Guides CiteScore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0